Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$123,467,238
-$12,137,736 QoQ
Shares Held
5,127,377
+6.2% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#89
of 2,826 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $2,885,207,124 across 10 Drug Manufacturers - General names. PFE ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
895,262 | $1,073,804,190 | |
| 2 | JNJ |
Johnson & Johnson
|
2,064,646 | $524,358,144 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,364,831 | $432,380,783 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,940,617 | $245,177,551 | |
| 5 | ABBV |
AbbVie Inc.
|
861,436 | $216,771,755 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,865,663 | $165,119,502 | |
| 7 | PFE |
Pfizer Inc
This page
|
5,127,377 | $123,467,238 | |
| 8 | AMGN |
Amgen Inc
|
236,929 | $85,796,729 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,467,238 | 5,127,377 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $135,604,974 | 4,829,237 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $133,399,857 | 5,357,424 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $130,551,162 | 5,123,672 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $126,236,441 | 5,207,774 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $159,692,984 | 6,302,012 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $170,986,141 | 6,445,011 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $146,485,771 | 5,061,706 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $144,482,256 | 5,163,769 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $150,553,379 | 5,425,347 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $145,744,048 | 5,062,315 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $109,144,392 | 3,290,455 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $129,826,255 | 3,539,429 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $217,759,718 | 5,337,248 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $303,445,124 | 5,922,036 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $281,968,172 | 6,443,514 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $305,968,477 | 5,835,752 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $297,929,309 | 5,754,864 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $395,629,390 | 6,699,905 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $211,781,283 | 4,924,001 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $163,007,925 | 4,162,613 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $152,577,862 | 4,211,368 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $157,682,776 | 4,283,694 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $95,868,379 | 2,612,220 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $86,321,778 | 2,639,807 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $84,115,320 | 2,577,066 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||